ERBB2 and breast carcinoma: This report raised the hypothesis that HER2+ breast cancer cells attract and educate macrophages into CD206-positive but not CD163-positive M2-like cells, which was in line with the results from two clinical studies 13, 28 that found CD206-positive macrophages were more likely to be associated with HER2-positive breast cancer.